Harvard Bioscience (HBIO) Current Taxes (2010 - 2023)

Harvard Bioscience (HBIO) has 14 years of Current Taxes data on file, last reported at $398000.0 in Q2 2023.

• On a quarterly basis, Current Taxes rose 665.38% year-over-year to $398000.0 in Q2 2023; TTM through Jun 2023 was $398000.0, a 665.38% increase from a year earlier, with the FY2021 full-year figure at $224000.0, down 21.68% from the prior year.
• Current Taxes for Q2 2023 stood at $398000.0, down from $700000.0 in the prior quarter.
• Over the last five years, Current Taxes for HBIO reached as high as $1.3 million in Q1 2019 and fell as low as $52000.0 in Q2 2022.
• Historically, Current Taxes has averaged $505250.0 across 5 years, with a median of $471000.0 in 2021.
• Across the five-year window, Current Taxes jumped 3121.05% in 2019 and sank 90.44% in 2022, its largest moves.
• Year by year, Current Taxes stood at $609000.0 in 2019, then sank by 53.04% to $286000.0 in 2020, then declined by 21.68% to $224000.0 in 2021, then plunged by 76.79% to $52000.0 in 2022, then surged by 665.38% to $398000.0 in 2023.
• Per Business Quant data, the three most recent Current Taxes figures were $398000.0 in Q2 2023, $700000.0 in Q1 2023, and $52000.0 in Q2 2022.